Table of Content

1 Psychiatric and Nervous Drugs Market Overview
1.1 Psychiatric and Nervous Drugs Product Overview
1.2 Psychiatric and Nervous Drugs Market Segment by Type
1.2.1 Antidepressants
1.2.2 Anti-anxiety
1.2.3 Antipsychotic
1.2.4 Mood Stabilizing
1.2.5 Stimulant Medications
1.2.6 Others
1.3 Global Psychiatric and Nervous Drugs Market Size by Type
1.3.1 Global Psychiatric and Nervous Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Psychiatric and Nervous Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Psychiatric and Nervous Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Psychiatric and Nervous Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Psychiatric and Nervous Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Psychiatric and Nervous Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Psychiatric and Nervous Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Psychiatric and Nervous Drugs Sales Breakdown by Type (2024-2024)
2 Global Psychiatric and Nervous Drugs Market Competition by Company
2.1 Global Top Players by Psychiatric and Nervous Drugs Sales (2024-2024)
2.2 Global Top Players by Psychiatric and Nervous Drugs Revenue (2024-2024)
2.3 Global Top Players by Psychiatric and Nervous Drugs Price (2024-2024)
2.4 Global Top Manufacturers Psychiatric and Nervous Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Psychiatric and Nervous Drugs Market Competitive Situation and Trends
2.5.1 Psychiatric and Nervous Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Psychiatric and Nervous Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psychiatric and Nervous Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Psychiatric and Nervous Drugs Market
2.8 Key Manufacturers Psychiatric and Nervous Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Psychiatric and Nervous Drugs Status and Outlook by Region
3.1 Global Psychiatric and Nervous Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Psychiatric and Nervous Drugs Historic Market Size by Region
3.2.1 Global Psychiatric and Nervous Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Psychiatric and Nervous Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Psychiatric and Nervous Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Psychiatric and Nervous Drugs Forecasted Market Size by Region
3.3.1 Global Psychiatric and Nervous Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Psychiatric and Nervous Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Psychiatric and Nervous Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Psychiatric and Nervous Drugs by Application
4.1 Psychiatric and Nervous Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Psychiatric and Nervous Drugs Market Size by Application
4.2.1 Global Psychiatric and Nervous Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Psychiatric and Nervous Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Psychiatric and Nervous Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Psychiatric and Nervous Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Psychiatric and Nervous Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Psychiatric and Nervous Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Psychiatric and Nervous Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Psychiatric and Nervous Drugs Sales Breakdown by Application (2024-2024)
5 North America Psychiatric and Nervous Drugs by Country
5.1 North America Psychiatric and Nervous Drugs Historic Market Size by Country
5.1.1 North America Psychiatric and Nervous Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Psychiatric and Nervous Drugs Sales in Value by Country (2024-2024)
5.2 North America Psychiatric and Nervous Drugs Forecasted Market Size by Country
5.2.1 North America Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Psychiatric and Nervous Drugs Sales in Value by Country (2024-2034)
6 Europe Psychiatric and Nervous Drugs by Country
6.1 Europe Psychiatric and Nervous Drugs Historic Market Size by Country
6.1.1 Europe Psychiatric and Nervous Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Psychiatric and Nervous Drugs Sales in Value by Country (2024-2024)
6.2 Europe Psychiatric and Nervous Drugs Forecasted Market Size by Country
6.2.1 Europe Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Psychiatric and Nervous Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Psychiatric and Nervous Drugs by Region
7.1 Asia-Pacific Psychiatric and Nervous Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Psychiatric and Nervous Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Psychiatric and Nervous Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Psychiatric and Nervous Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Psychiatric and Nervous Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Psychiatric and Nervous Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Psychiatric and Nervous Drugs Sales in Value by Region (2024-2034)
8 Latin America Psychiatric and Nervous Drugs by Country
8.1 Latin America Psychiatric and Nervous Drugs Historic Market Size by Country
8.1.1 Latin America Psychiatric and Nervous Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Psychiatric and Nervous Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Psychiatric and Nervous Drugs Forecasted Market Size by Country
8.2.1 Latin America Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Psychiatric and Nervous Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Psychiatric and Nervous Drugs by Country
9.1 Middle East and Africa Psychiatric and Nervous Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Psychiatric and Nervous Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Psychiatric and Nervous Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Psychiatric and Nervous Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Psychiatric and Nervous Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Psychiatric and Nervous Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer Psychiatric and Nervous Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Ely Lilly
10.2.1 Ely Lilly Company Information
10.2.2 Ely Lilly Introduction and Business Overview
10.2.3 Ely Lilly Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Ely Lilly Psychiatric and Nervous Drugs Products Offered
10.2.5 Ely Lilly Recent Development
10.3 Actavis
10.3.1 Actavis Company Information
10.3.2 Actavis Introduction and Business Overview
10.3.3 Actavis Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Actavis Psychiatric and Nervous Drugs Products Offered
10.3.5 Actavis Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Mylan Psychiatric and Nervous Drugs Products Offered
10.4.5 Mylan Recent Development
10.5 Randox
10.5.1 Randox Company Information
10.5.2 Randox Introduction and Business Overview
10.5.3 Randox Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Randox Psychiatric and Nervous Drugs Products Offered
10.5.5 Randox Recent Development
10.6 Intellipharmaceutics
10.6.1 Intellipharmaceutics Company Information
10.6.2 Intellipharmaceutics Introduction and Business Overview
10.6.3 Intellipharmaceutics Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Intellipharmaceutics Psychiatric and Nervous Drugs Products Offered
10.6.5 Intellipharmaceutics Recent Development
10.7 Astrazeneca
10.7.1 Astrazeneca Company Information
10.7.2 Astrazeneca Introduction and Business Overview
10.7.3 Astrazeneca Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Astrazeneca Psychiatric and Nervous Drugs Products Offered
10.7.5 Astrazeneca Recent Development
10.8 Lundbeck
10.8.1 Lundbeck Company Information
10.8.2 Lundbeck Introduction and Business Overview
10.8.3 Lundbeck Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Lundbeck Psychiatric and Nervous Drugs Products Offered
10.8.5 Lundbeck Recent Development
10.9 Allergan
10.9.1 Allergan Company Information
10.9.2 Allergan Introduction and Business Overview
10.9.3 Allergan Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Allergan Psychiatric and Nervous Drugs Products Offered
10.9.5 Allergan Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 GSK Psychiatric and Nervous Drugs Products Offered
10.10.5 GSK Recent Development
10.11 Otsuka Pharmaceutical
10.11.1 Otsuka Pharmaceutical Company Information
10.11.2 Otsuka Pharmaceutical Introduction and Business Overview
10.11.3 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Otsuka Pharmaceutical Psychiatric and Nervous Drugs Products Offered
10.11.5 Otsuka Pharmaceutical Recent Development
10.12 Takeda
10.12.1 Takeda Company Information
10.12.2 Takeda Introduction and Business Overview
10.12.3 Takeda Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Takeda Psychiatric and Nervous Drugs Products Offered
10.12.5 Takeda Recent Development
10.13 NHU Group
10.13.1 NHU Group Company Information
10.13.2 NHU Group Introduction and Business Overview
10.13.3 NHU Group Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.13.4 NHU Group Psychiatric and Nervous Drugs Products Offered
10.13.5 NHU Group Recent Development
10.14 Shionogi
10.14.1 Shionogi Company Information
10.14.2 Shionogi Introduction and Business Overview
10.14.3 Shionogi Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Shionogi Psychiatric and Nervous Drugs Products Offered
10.14.5 Shionogi Recent Development
10.15 APOTEX
10.15.1 APOTEX Company Information
10.15.2 APOTEX Introduction and Business Overview
10.15.3 APOTEX Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.15.4 APOTEX Psychiatric and Nervous Drugs Products Offered
10.15.5 APOTEX Recent Development
10.16 Chengdu Kanghong Pharmaceutical
10.16.1 Chengdu Kanghong Pharmaceutical Company Information
10.16.2 Chengdu Kanghong Pharmaceutical Introduction and Business Overview
10.16.3 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Products Offered
10.16.5 Chengdu Kanghong Pharmaceutical Recent Development
10.17 HUAHAI
10.17.1 HUAHAI Company Information
10.17.2 HUAHAI Introduction and Business Overview
10.17.3 HUAHAI Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.17.4 HUAHAI Psychiatric and Nervous Drugs Products Offered
10.17.5 HUAHAI Recent Development
10.18 Zhejiang Jianfeng
10.18.1 Zhejiang Jianfeng Company Information
10.18.2 Zhejiang Jianfeng Introduction and Business Overview
10.18.3 Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Zhejiang Jianfeng Psychiatric and Nervous Drugs Products Offered
10.18.5 Zhejiang Jianfeng Recent Development
10.19 Beijing Winsunny Pharmaceutical
10.19.1 Beijing Winsunny Pharmaceutical Company Information
10.19.2 Beijing Winsunny Pharmaceutical Introduction and Business Overview
10.19.3 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Products Offered
10.19.5 Beijing Winsunny Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Psychiatric and Nervous Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Psychiatric and Nervous Drugs Industrial Chain Analysis
11.4 Psychiatric and Nervous Drugs Market Dynamics
11.4.1 Psychiatric and Nervous Drugs Industry Trends
11.4.2 Psychiatric and Nervous Drugs Market Drivers
11.4.3 Psychiatric and Nervous Drugs Market Challenges
11.4.4 Psychiatric and Nervous Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Psychiatric and Nervous Drugs Distributors
12.3 Psychiatric and Nervous Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antidepressants
Table 2. Major Company of Anti-anxiety
Table 3. Major Company of Antipsychotic
Table 4. Major Company of Mood Stabilizing
Table 5. Major Company of Stimulant Medications
Table 6. Major Company of Others
Table 7. Global Psychiatric and Nervous Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 8. Global Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (K Units)
Table 9. Global Psychiatric and Nervous Drugs Sales Market Share in Volume by Type (2024-2024)
Table 10. Global Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (US& Million)
Table 11. Global Psychiatric and Nervous Drugs Market Share in Value by Type (2024-2024)
Table 12. Global Psychiatric and Nervous Drugs Price by Type (2024-2024) & (US$/Unit)
Table 13. Global Psychiatric and Nervous Drugs Sales by Type (2024-2034) & (K Units)
Table 14. Global Psychiatric and Nervous Drugs Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Psychiatric and Nervous Drugs Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Psychiatric and Nervous Drugs Sales Market Share in Value by Type (2024-2034)
Table 17. Global Psychiatric and Nervous Drugs Price by Type (2024-2034) & (US$/Unit)
Table 18. North America Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (K Units)
Table 19. North America Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (US$ Million)
Table 20. Europe Psychiatric and Nervous Drugs Sales (K Units) by Type (2024-2024)
Table 21. Europe Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (US$ Million)
Table 22. Asia-Pacific Psychiatric and Nervous Drugs Sales (K Units) by Type (2024-2024)
Table 23. Asia-Pacific Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (US$ Million)
Table 24. Latin America Psychiatric and Nervous Drugs Sales (K Units) by Type (2024-2024)
Table 25. Latin America Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (US$ Million)
Table 26. Middle East and Africa Psychiatric and Nervous Drugs Sales (K Units) by Type (2024-2024)
Table 27. Middle East and Africa Psychiatric and Nervous Drugs Sales by Type (2024-2024) & (US$ Million)
Table 28. Global Psychiatric and Nervous Drugs Sales by Company (2024-2024) & (K Units)
Table 29. Global Psychiatric and Nervous Drugs Sales Share by Company (2024-2024)
Table 30. Global Psychiatric and Nervous Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 31. Global Psychiatric and Nervous Drugs Revenue Share by Company (2024-2024)
Table 32. Global Market Psychiatric and Nervous Drugs Price by Company (2024-2024) & (US$/Unit)
Table 33. Global Psychiatric and Nervous Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Psychiatric and Nervous Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psychiatric and Nervous Drugs as of 2022)
Table 36. Date of Key Manufacturers Enter into Psychiatric and Nervous Drugs Market
Table 37. Key Manufacturers Psychiatric and Nervous Drugs Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Psychiatric and Nervous Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Global Psychiatric and Nervous Drugs Sales by Region (2024-2024) & (K Units)
Table 41. Global Psychiatric and Nervous Drugs Sales Market Share in Volume by Region (2024-2024)
Table 42. Global Psychiatric and Nervous Drugs Sales by Region (2024-2024) & (US$ Million)
Table 43. Global Psychiatric and Nervous Drugs Sales Market Share in Value by Region (2024-2024)
Table 44. Global Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 45. Global Psychiatric and Nervous Drugs Sales by Region (2024-2034) & (K Units)
Table 46. Global Psychiatric and Nervous Drugs Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Psychiatric and Nervous Drugs Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Psychiatric and Nervous Drugs Sales Market Share in Value by Region (2024-2034)
Table 49. Global Psychiatric and Nervous Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 50. Global Psychiatric and Nervous Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 51. Global Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (K Units)
Table 52. Global Psychiatric and Nervous Drugs Sales Market Share in Volume by Application (2024-2024)
Table 53. Global Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (US$ Million)
Table 54. Global Psychiatric and Nervous Drugs Sales Market Share in Value by Application (2024-2024)
Table 55. Global Psychiatric and Nervous Drugs Price by Application (2024-2024) & (US$/Unit)
Table 56. Global Psychiatric and Nervous Drugs Sales by Application (2024-2034) & (K Units)
Table 57. Global Psychiatric and Nervous Drugs Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Psychiatric and Nervous Drugs Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Psychiatric and Nervous Drugs Sales Market Share in Value by Application (2024-2034)
Table 60. Global Psychiatric and Nervous Drugs Price by Application (2024-2034) & (US$/Unit)
Table 61. North America Psychiatric and Nervous Drugs Sales by Application (2024-2024) (K Units)
Table 62. North America Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (US$ Million)
Table 63. Europe Psychiatric and Nervous Drugs Sales by Application (2024-2024) (K Units)
Table 64. Europe Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (US$ Million)
Table 65. Asia-Pacific Psychiatric and Nervous Drugs Sales by Application (2024-2024) (K Units)
Table 66. Asia-Pacific Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (US$ Million)
Table 67. Latin America Psychiatric and Nervous Drugs Sales by Application (2024-2024) (K Units)
Table 68. Latin America Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (US$ Million)
Table 69. Middle East and Africa Psychiatric and Nervous Drugs Sales by Application (2024-2024) (K Units)
Table 70. Middle East and Africa Psychiatric and Nervous Drugs Sales by Application (2024-2024) & (US$ Million)
Table 71. North America Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (K Units)
Table 72. North America Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2024)
Table 73. North America Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (US$ Million)
Table 74. North America Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2024)
Table 75. North America Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (K Units)
Table 76. North America Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (K Units)
Table 80. Europe Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2024)
Table 81. Europe Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (US$ Million)
Table 82. Europe Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2024)
Table 83. Europe Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (K Units)
Table 84. Europe Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Psychiatric and Nervous Drugs Sales by Region (2024-2024) & (K Units)
Table 88. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Volume by Region (2024-2024)
Table 89. Asia-Pacific Psychiatric and Nervous Drugs Sales by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Value by Region (2024-2024)
Table 91. Asia-Pacific Psychiatric and Nervous Drugs Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Psychiatric and Nervous Drugs Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (K Units)
Table 96. Latin America Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2024)
Table 97. Latin America Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (US$ Million)
Table 98. Latin America Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2024)
Table 99. Latin America Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (K Units)
Table 100. Latin America Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (K Units)
Table 104. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2024)
Table 105. Middle East and Africa Psychiatric and Nervous Drugs Sales by Country (2024-2024) & (US$ Million)
Table 106. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2024)
Table 107. Middle East and Africa Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Psychiatric and Nervous Drugs Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Value by Country (2024-2034)
Table 111. Pfizer Company Information
Table 112. Pfizer Introduction and Business Overview
Table 113. Pfizer Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 114. Pfizer Psychiatric and Nervous Drugs Product
Table 115. Pfizer Recent Development
Table 116. Ely Lilly Company Information
Table 117. Ely Lilly Introduction and Business Overview
Table 118. Ely Lilly Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 119. Ely Lilly Psychiatric and Nervous Drugs Product
Table 120. Ely Lilly Recent Development
Table 121. Actavis Company Information
Table 122. Actavis Introduction and Business Overview
Table 123. Actavis Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 124. Actavis Psychiatric and Nervous Drugs Product
Table 125. Actavis Recent Development
Table 126. Mylan Company Information
Table 127. Mylan Introduction and Business Overview
Table 128. Mylan Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 129. Mylan Psychiatric and Nervous Drugs Product
Table 130. Mylan Recent Development
Table 131. Randox Company Information
Table 132. Randox Introduction and Business Overview
Table 133. Randox Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 134. Randox Psychiatric and Nervous Drugs Product
Table 135. Randox Recent Development
Table 136. Intellipharmaceutics Company Information
Table 137. Intellipharmaceutics Introduction and Business Overview
Table 138. Intellipharmaceutics Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 139. Intellipharmaceutics Psychiatric and Nervous Drugs Product
Table 140. Intellipharmaceutics Recent Development
Table 141. Astrazeneca Company Information
Table 142. Astrazeneca Introduction and Business Overview
Table 143. Astrazeneca Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 144. Astrazeneca Psychiatric and Nervous Drugs Product
Table 145. Astrazeneca Recent Development
Table 146. Lundbeck Company Information
Table 147. Lundbeck Introduction and Business Overview
Table 148. Lundbeck Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 149. Lundbeck Psychiatric and Nervous Drugs Product
Table 150. Lundbeck Recent Development
Table 151. Allergan Company Information
Table 152. Allergan Introduction and Business Overview
Table 153. Allergan Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 154. Allergan Psychiatric and Nervous Drugs Product
Table 155. Allergan Recent Development
Table 156. GSK Company Information
Table 157. GSK Introduction and Business Overview
Table 158. GSK Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 159. GSK Psychiatric and Nervous Drugs Product
Table 160. GSK Recent Development
Table 161. Otsuka Pharmaceutical Company Information
Table 162. Otsuka Pharmaceutical Introduction and Business Overview
Table 163. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 164. Otsuka Pharmaceutical Psychiatric and Nervous Drugs Product
Table 165. Otsuka Pharmaceutical Recent Development
Table 166. Takeda Company Information
Table 167. Takeda Introduction and Business Overview
Table 168. Takeda Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 169. Takeda Psychiatric and Nervous Drugs Product
Table 170. Takeda Recent Development
Table 171. NHU Group Company Information
Table 172. NHU Group Introduction and Business Overview
Table 173. NHU Group Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 174. NHU Group Psychiatric and Nervous Drugs Product
Table 175. NHU Group Recent Development
Table 176. Shionogi Company Information
Table 177. Shionogi Introduction and Business Overview
Table 178. Shionogi Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 179. Shionogi Psychiatric and Nervous Drugs Product
Table 180. Shionogi Recent Development
Table 181. APOTEX Company Information
Table 182. APOTEX Introduction and Business Overview
Table 183. APOTEX Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 184. APOTEX Psychiatric and Nervous Drugs Product
Table 185. APOTEX Recent Development
Table 186. Chengdu Kanghong Pharmaceutical Company Information
Table 187. Chengdu Kanghong Pharmaceutical Introduction and Business Overview
Table 188. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 189. Chengdu Kanghong Pharmaceutical Psychiatric and Nervous Drugs Product
Table 190. Chengdu Kanghong Pharmaceutical Recent Development
Table 191. HUAHAI Company Information
Table 192. HUAHAI Introduction and Business Overview
Table 193. HUAHAI Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 194. HUAHAI Psychiatric and Nervous Drugs Product
Table 195. HUAHAI Recent Development
Table 196. Zhejiang Jianfeng Company Information
Table 197. Zhejiang Jianfeng Introduction and Business Overview
Table 198. Zhejiang Jianfeng Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 199. Zhejiang Jianfeng Psychiatric and Nervous Drugs Product
Table 200. Zhejiang Jianfeng Recent Development
Table 201. Beijing Winsunny Pharmaceutical Company Information
Table 202. Beijing Winsunny Pharmaceutical Introduction and Business Overview
Table 203. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 204. Beijing Winsunny Pharmaceutical Psychiatric and Nervous Drugs Product
Table 205. Beijing Winsunny Pharmaceutical Recent Development
Table 206. Key Raw Materials Lists
Table 207. Raw Materials Key Suppliers Lists
Table 208. Psychiatric and Nervous Drugs Market Trends
Table 209. Psychiatric and Nervous Drugs Market Drivers
Table 210. Psychiatric and Nervous Drugs Market Challenges
Table 211. Psychiatric and Nervous Drugs Market Restraints
Table 212. Psychiatric and Nervous Drugs Distributors List
Table 213. Psychiatric and Nervous Drugs Downstream Customers
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Psychiatric and Nervous Drugs Product Picture
Figure 2. Global Psychiatric and Nervous Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Psychiatric and Nervous Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Psychiatric and Nervous Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Antidepressants
Figure 6. Global Antidepressants Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Anti-anxiety
Figure 8. Global Anti-anxiety Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Antipsychotic
Figure 10. Global Antipsychotic Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Mood Stabilizing
Figure 12. Global Mood Stabilizing Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Stimulant Medications
Figure 14. Global Stimulant Medications Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Global Psychiatric and Nervous Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 18. Global Psychiatric and Nervous Drugs Sales Market Share by Type in 2022 & 2034
Figure 19. North America Psychiatric and Nervous Drugs Sales Market Share in Volume by Type in 2022
Figure 20. North America Psychiatric and Nervous Drugs Sales Market Share in Value by Type in 2022
Figure 21. Europe Psychiatric and Nervous Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Europe Psychiatric and Nervous Drugs Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Value by Type in 2022
Figure 25. Latin America Psychiatric and Nervous Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Psychiatric and Nervous Drugs Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Psychiatric and Nervous Drugs Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Psychiatric and Nervous Drugs Revenue in 2022
Figure 31. Psychiatric and Nervous Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 32. Product Picture of Hospital Pharmacies
Figure 33. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Retail Pharmacies
Figure 35. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Online Pharmacies
Figure 37. Global Online Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Psychiatric and Nervous Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Psychiatric and Nervous Drugs Sales Market Share by Application in 2022 & 2034
Figure 40. North America Psychiatric and Nervous Drugs Sales Market Share in Volume by Application in 2022
Figure 41. North America Psychiatric and Nervous Drugs Sales Market Share in Value by Application in 2022
Figure 42. Europe Psychiatric and Nervous Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Europe Psychiatric and Nervous Drugs Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Psychiatric and Nervous Drugs Sales Market Share in Value by Application in 2022
Figure 46. Latin America Psychiatric and Nervous Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Psychiatric and Nervous Drugs Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Psychiatric and Nervous Drugs Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Psychiatric and Nervous Drugs Manufacturing Cost Structure
Figure 51. Psychiatric and Nervous Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed